Evidence-based value and access strategies

Principals: Barbara Pannone


Barbara Pannone, PhD
Vice President, Consulting Strategy and Operations

Barbara, a member of the Compass team since 2006, brings experience as a research scientist plus strong analysis and communications skills. She is responsible for leading our team of analysts and consultants in the execution of all key projects. Since joining Compass, she has managed projects in a variety of therapeutic areas including cardiovascular diseases, T2DM, oncology, orphan diseases, and acute care. She has helped develop strategic conclusions and recommendations for various US and global market access assessments, pricing and reimbursement assessments and due diligence assessments.

Prior to joining Compass, Barbara worked as a Postdoctoral Associate at Yale University where she studied RNA binding proteins and their role in protein/RNA complex assembly. She received a PhD in Cell and Molecular Biology from Yale University where she studied the function of the lupus autoantibody La and how it is involved in RNA biogenesis. Barbara has been the lead author on several scientific papers on RNA binding proteins and has co-authored and edited a number of others. In addition to a PhD from Yale University, Barbara earned a B.S. in Biology from Brown University. She also interned with Bayer R&D in the Alzheimer’s Research Group.

Barbara is highly successful in managing our intelligence and analytical efforts and ensuring that our findings are accurate, and our reports top quality and delivered on time.

Meet Our Principals

Paul GallagherPaul Gallagher, MBA
President

Barbara Pannone, PhD
VP, Consulting Strategy and Operations

SM_maximilian-vargasMaximilian Vargas, PhD, MBA
VP, Consulting Strategy and Account Management

SM_EdGallagherEdward Gallagher, MS
Global Pricing Strategy Leader

SM_nicolas_touchotNicolas Touchot, PhD
Europe Lead